These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24399671)

  • 1. Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality.
    Lorent M; Giral M; Foucher Y
    Stat Med; 2014 Jun; 33(14):2379-89. PubMed ID: 24399671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic ROC curves: a method for representing the overall discriminative capacity of binary markers with right-censored time-to-event endpoints.
    Combescure C; Perneger TV; Weber DC; Daurès JP; Foucher Y
    Epidemiology; 2014 Jan; 25(1):103-9. PubMed ID: 24240658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal survival time-related cut-point with censored data.
    Liu X; Jin Z
    Stat Med; 2015 Feb; 34(3):515-24. PubMed ID: 25382379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiparametric estimation of time-dependent ROC curves for longitudinal marker data.
    Zheng Y; Heagerty PJ
    Biostatistics; 2004 Oct; 5(4):615-32. PubMed ID: 15475423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent ROC analysis for a three-class prognostic with application to kidney transplantation.
    Foucher Y; Giral M; Soulillou JP; Daures JP
    Stat Med; 2010 Dec; 29(30):3079-87. PubMed ID: 21170903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
    Hassan EA; Abd El-Rehim AS
    Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease.
    Cucchetti A; Vivarelli M; Heaton ND; Phillips S; Piscaglia F; Bolondi L; La Barba G; Foxton MR; Rela M; O'Grady J; Pinna AD
    Gut; 2007 Feb; 56(2):253-8. PubMed ID: 16809421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
    Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review and comparison of ROC curve estimators for a time-dependent outcome with marker-dependent censoring.
    Blanche P; Dartigues JF; Jacqmin-Gadda H
    Biom J; 2013 Sep; 55(5):687-704. PubMed ID: 23794418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers.
    Zheng Y; Cai T; Feng Z
    Biometrics; 2006 Mar; 62(1):279-87. PubMed ID: 16542256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time dependent ROC curves for the estimation of true prognostic capacity of microarray data.
    Foucher Y; Danger R
    Stat Appl Genet Mol Biol; 2012 Nov; 11(6):Article 1. PubMed ID: 23183763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival model predictive accuracy and ROC curves.
    Heagerty PJ; Zheng Y
    Biometrics; 2005 Mar; 61(1):92-105. PubMed ID: 15737082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic value of end-stage liver disease model in liver cirrhosis].
    Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis.
    Su CW; Chan CC; Hung HH; Huo TI; Huang YH; Li CP; Lin HC; Tsay SH; Lee PC; Lee SD; Wu JC
    J Clin Gastroenterol; 2009 Oct; 43(9):876-83. PubMed ID: 19247208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
    Corneille MG; Nicholson S; Richa J; Son C; Michalek J; Wolf SE; Stewart R
    J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-parametric estimation of a time-dependent predictive accuracy curve.
    Saha-Chaudhuri P; Heagerty PJ
    Biostatistics; 2013 Jan; 14(1):42-59. PubMed ID: 22734044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.